Agilon Health (NYSE:AGL) Shares Up 8.7% – Here’s Why

Shares of Agilon Health, Inc. (NYSE:AGLGet Free Report) were up 8.7% during trading on Friday . The company traded as high as $128.10 and last traded at $131.7970. 142,459 shares were traded during mid-day trading, a decline of 59% from the average session volume of 350,382 shares. The stock had previously closed at $121.22.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on AGL. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research report on Monday, May 4th. Benchmark reissued a “buy” rating and set a $95.00 price target (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Robert W. Baird increased their price objective on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Citigroup restated a “neutral” rating and issued a $80.00 price objective (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Finally, Weiss Ratings downgraded Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $64.00.

Check Out Our Latest Stock Report on Agilon Health

Agilon Health Trading Up 8.7%

The business has a 50-day simple moving average of $99.33 and a two-hundred day simple moving average of $46.95. The stock has a market cap of $2.20 billion, a price-to-earnings ratio of -6.12 and a beta of 2.98. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04.

Agilon Health (NYSE:AGLGet Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Equities analysts forecast that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Large investors have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. lifted its holdings in Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Agilon Health by 1,346.6% in the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after purchasing an additional 9,505,837 shares during the last quarter. North Peak Capital Management LLC raised its position in shares of Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares during the period. Voleon Capital Management LP lifted its stake in shares of Agilon Health by 5,519.2% during the 3rd quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock worth $2,823,000 after buying an additional 2,692,259 shares during the last quarter. Finally, UBS Group AG lifted its stake in shares of Agilon Health by 250.7% during the 4th quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock worth $2,339,000 after buying an additional 2,427,136 shares during the last quarter.

Agilon Health Company Profile

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

Further Reading

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.